Iana H Haralambieva Selected Research

Rubella (German Measles)

1/2021	Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age.
1/2020	Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
1/2019	Seroprevalence and durability of rubella virus antibodies in a highly immunized population.
1/2018	Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
1/2017	Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.
3/2015	Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.
11/2014	Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.
8/2014	Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.
4/2014	Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts.
1/2014	Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iana H Haralambieva Research Topics

Disease

23	Measles 01/2020 - 01/2011
18	Rubella (German Measles) 01/2021 - 01/2010
8	Smallpox (Variola) 01/2022 - 08/2011
8	Human Influenza (Influenza) 01/2018 - 12/2013
6	Infections 12/2022 - 12/2004
5	Mumps 01/2022 - 11/2011
5	Vaccinia 01/2022 - 08/2012
3	Virus Diseases (Viral Diseases) 01/2020 - 09/2011
2	Inflammation (Inflammations) 01/2013 - 02/2011
2	Neoplasms (Cancer) 08/2004 - 06/2002
1	COVID-19 12/2022
1	Poxviridae Infections 01/2020
1	Bites and Stings (Sting) 01/2020
1	Wilms Tumor (Wilm's Tumor) 01/2018
1	Febrile Seizures (Febrile Seizure) 01/2017
1	Communicable Diseases (Infectious Diseases) 05/2014
1	Hepatitis C 05/2014
1	Tuberculosis (Tuberculoses) 05/2014
1	Malaria 05/2014
1	Chlamydophila Infections 02/2002

Drug/Important Bio-Agent (IBA)

31	VaccinesIBA 01/2022 - 01/2010
21	Neutralizing AntibodiesIBA 12/2022 - 02/2011
19	CytokinesIBA 01/2022 - 02/2010
8	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2022 - 06/2011
8	Measles VaccineIBA 01/2019 - 02/2012
8	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2010
7	Messenger RNA (mRNA)IBA 12/2022 - 11/2012
7	Immunoglobulin G (IgG)IBA 01/2020 - 04/2010
7	AntibodiesIBA 01/2019 - 01/2011
7	Interleukin-2 (IL2)IBA 10/2013 - 04/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
5	Cytokine Receptors (Cytokine Receptor)IBA 11/2014 - 10/2011
4	AntigensIBA 12/2022 - 01/2018
4	Interleukin-10 (Interleukin 10)IBA 02/2012 - 01/2011
3	ProteomeIBA 01/2022 - 03/2015
3	ImmunosorbentsIBA 01/2020 - 01/2012
3	EnzymesIBA 01/2020 - 01/2012
3	Antiviral Agents (Antivirals)IBA 11/2014 - 02/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 02/2010
2	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 01/2022 - 10/2013
2	ChemokinesIBA 01/2022 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
2	InterferonsIBA 01/2018 - 01/2012
2	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2016 - 01/2016
2	Interleukin-18 (Interleukin 18)IBA 11/2013 - 08/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2010 - 02/2010
2	Vitamin A (Retinol)FDA LinkGeneric 02/2010 - 01/2010
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	ElementsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Mumps Vaccine (Vaccine, Mumps)IBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2020
1	LigandsIBA 01/2020
1	Fc Receptors (Fc Receptor)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	CholesterolIBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	HLA-DPB1 antigen (HLA DPB1)IBA 03/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2014
1	Cell Surface ReceptorsIBA 01/2014
1	Serine Proteases (Serine Protease)IBA 12/2013
1	Granzymes (Granzyme)IBA 12/2013
1	HLA-A Antigens (HLA-A)IBA 01/2013
1	HLA-B Antigens (HLA-B)IBA 01/2013
1	InterleukinsIBA 01/2012
1	Hemagglutinins (Hemagglutinin)IBA 06/2011
1	Virulence Factors (Pathogenicity Factors)IBA 02/2011
1	Viral VaccinesIBA 01/2011
1	Interleukin-12 Subunit p40IBA 04/2010
1	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2010
1	5' Untranslated Regions (5' UTR)IBA 01/2010
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 12/2004
1	Immunoglobulin A (IgA)IBA 08/2004
1	Secretory Immunoglobulin A (SIgA)IBA 06/2002
1	LectinsIBA 02/2002

Therapy/Procedure

1	Intraperitoneal Injections 02/2011